Effect of Periodic Granulocyte Colony-Stimulating Factor Administration on Endothelial Progenitor Cells and Different Monocyte Subsets in Pediatric Patients with Muscular Dystrophies.
Andrzej EljaszewiczDorota SienkiewiczKamil GrubczakBożena Okurowska-ZawadaGrażyna Paszko-PatejPaula MiklaszPaulina SinghUrszula RadzikowskaWojciech KulakMarcin MoniuszkoPublished in: Stem cells international (2015)
Muscular dystrophies (MD) are heterogeneous group of diseases characterized by progressive muscle dysfunction. There is a large body of evidence indicating that angiogenesis is impaired in muscles of MD patients. Therefore, induction of dystrophic muscle revascularization should become a novel approach aimed at diminishing the extent of myocyte damage. Recently, we and others demonstrated that administration of granulocyte colony-stimulating factor (G-CSF) resulted in clinical improvement of patients with neuromuscular disorders. To date, however, the exact mechanisms underlying these beneficial effects of G-CSF have not been fully understood. Here we used flow cytometry to quantitate numbers of CD34+ cells, endothelial progenitor cells, and different monocyte subsets in peripheral blood of pediatric MD patients treated with repetitive courses of G-CSF administration. We showed that repetitive cycles of G-CSF administration induced efficient mobilization of above-mentioned cells including cells with proangiogenic potential. These findings contribute to better understanding the beneficial clinical effects of G-CSF in pediatric MD patients.
Keyphrases
- peripheral blood
- induced apoptosis
- end stage renal disease
- endothelial cells
- cell cycle arrest
- ejection fraction
- newly diagnosed
- flow cytometry
- chronic kidney disease
- molecular dynamics
- oxidative stress
- prognostic factors
- dendritic cells
- peritoneal dialysis
- skeletal muscle
- high frequency
- signaling pathway
- endoplasmic reticulum stress
- young adults
- atrial fibrillation
- coronary artery bypass grafting
- density functional theory
- body composition
- drug induced
- percutaneous coronary intervention
- vascular endothelial growth factor
- pi k akt